Actavis Strikes Deal With Valeant Over Generic Acne Gel
Actavis PLC said Monday that is has entered into an agreement with Canadian drugmaker Valeant Pharmaceuticals International Inc. to settle outstanding patent litigation over Actavis' generic version of the medicated acne...To view the full article, register now.
Already a subscriber? Click here to view full article